Advanced search
Publication Cover
Vascular Health and Risk Management Volume 10, 2014 - Issue
Submit an article Journal homepage
69
Views
2
CrossRef citations to date
0
Altmetric
Review

Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes

Angela DardanoDepartment of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Diseases, University of Pisa, Pisa, ItalyCorrespondence[email protected]
,
Cristina BianchiDepartment of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Diseases, University of Pisa, Pisa, Italy
,
Stefano Del PratoDepartment of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Diseases, University of Pisa, Pisa, Italy
&
Roberto MiccoliDepartment of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Diseases, University of Pisa, Pisa, Italy
Pages 465-475 | Published online: 05 Aug 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kai Pan, Xiaolei Shi, Kai Liu, Ju Wang & Yijun Chen. (2021) Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats. Drug Design, Development and Therapy 15, pages 3487-3498.
Read now

Articles from other publishers (1)

Hatice Oner, Hatice Gizem Gunhan & Dilek Gogas Yavuz. (2022) Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience. Frontiers in Clinical Diabetes and Healthcare 3.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.